Abbott Laboratories ($ABT) Stock Forecast: Up 5.4% Today

What is Abbott Laboratories?

Abbott Laboratories (NYSE: ABT) operates in the global healthcare sector, focusing on pharmaceuticals, medical devices, diagnostics, and nutrition products. Today, the company experienced a significant bullish trend in the market.

Why is Abbott Laboratories going up?

ABT stock is up 5.4% on Apr 16, 2025 14:35

• Abbott Laboratories reported positive Q1 earnings, with sales increasing by 7.2% and adjusted EPS surpassing consensus estimates, potentially influencing the uptick in ABT stock.
• The company's strong performance in the Medical Device segment, notably with products like FreeStyle Libre and heart-related devices, demonstrated its resilience in uncertain times and its ability to drive growth.
• The purchase of a substantial amount of ABT stock by a member of the House of Representatives might have boosted investor confidence in the company's future, leading to increased buying activity and pushing the stock price up.
• Despite the overall market decline witnessed today, Abbott Laboratories' robust financial results, favorable market sentiment, and strategic growth initiatives likely propelled the bullish trend in ABT stock.

ABT Price Chart

ABT Technical Analysis

ABT News

Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings - Abbott Laboratories ( NYSE:ABT ) , Biomerica ( NASDAQ:BMRA )

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 2% on Wednesday. The Dow traded down 0.67% to 40,099.73 while the NASDAQ dipped 2.12% to 16,466.96. The S&P 500 also fell, dropping, 1.27% to 5,327.95. Energy shares surged by 1.4% on Wednesday.

https://www.benzinga.com/25/04/44840040/nasdaq-down-over-2-abbott-laboratories-posts-upbeat-earnings

Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty - Abbott Laboratories ( NYSE:ABT )

Q1 sales rose 7.2% to $10.36 billion; adjusted EPS of $1.09 beat the consensus of $1.07 and topped the guidance range. Medical Device sales hit $4.89 billion, up 9.9%, led by FreeStyle Libre and heart-related product growth.

https://www.benzinga.com/general/health-care/25/04/44838946/abbott-labs-clocks-q1-profit-beat-ceo-says-diversification-and-execution-enable-navigation-du

Abbott Laboratories, Travelers Companies And 3 Stocks To Watch Heading Into Wednesday - Abbott Laboratories ( NYSE:ABT ) , ASML Holding ( NASDAQ:ASML )

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Abbott Laboratories ABT to report quarterly earnings at $1.07 per share on revenue of $10.40 billion before the opening bell, according to ...

https://www.benzinga.com/25/04/44831969/abbott-laboratories-travelers-companies-and-3-stocks-to-watch-heading-into-wednesday

This House of Representative Just Bought Up To $390K In Abbott Laboratories Stock - Abbott Laboratories ( NYSE:ABT ) , Amazon.com ( NASDAQ:AMZN )

Records from April 14, 2025 indicate that Representative Byron Donalds of Florida made a purchase of Abbott Laboratories ABT, valued between $26,026 and $390,000, with the transaction dated April 14, 2025 and filed in April. As of now, Abbott Laboratories shares are trading down 0.46% at $126.78.

https://www.benzinga.com/insights/government/25/04/44816766/this-house-of-representative-just-bought-up-to-390k-in-abbott-laboratories-stock

How To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings - Abbott Laboratories ( NYSE:ABT )

A more conservative goal of $100 monthly dividend income would require 508 shares of Abbott. An investor would need to own $325,274 worth of Abbott Laboratories to generate a monthly dividend income of $500. China's new tariffs just reignited the same market patterns that led to triple- and ...

https://www.benzinga.com/news/earnings/25/04/44811469/how-to-earn-500-a-month-from-abbott-laboratories-stock-ahead-of-q1-earnings

Trending Today

Memecoin ($MEME) Crypto Forecast: Up 31.2% Today

ApeCoin ($APE) Crypto Forecast: Up 5.1% Today

JasmyCoin ($JASMY) Crypto Forecast: Up 5.2% Today

Bittensor ($TAO) Crypto Forecast: Up 6.3% Today

Fetch.ai ($FET) Crypto Forecast: Up 7.2% Today

Arbitrum ($ARB) Crypto Forecast: Up 5.1% Today

Filecoin ($FIL) Crypto Forecast: Up 5.2% Today

PancakeSwap ($CAKE) Crypto Forecast: Up 6.6% Today

Aptos ($APT) Crypto Forecast: Up 5.2% Today

Ethena ($ENA) Crypto Forecast: Up 5.3% Today

Abbott Laboratories Price History

16.09.2024 - ABT Stock was down 0.1%

• Despite strong Q3 earnings surpassing expectations, ABT's stock saw a bearish trend today.
• The market reaction may have been influenced by mixed U.S. stock futures trading, impacting investor sentiment towards healthcare stocks like ABT.
• Today’s 2.26% decline in stock price could be due to profit-taking by investors following a period of consistent growth.
• While ABT remains on track to meet its annual forecast, short-term market movements and overall market conditions likely played a role in today's bearish performance.

07.05.2024 - ABT Stock was up 1.3%

• ABT stock experienced a bullish movement today, likely driven by multiple factors:
• The positive outlook on dividend-paying companies in the current market environment could have attracted investors to ABT due to its strong dividend track record.
• The average brokerage recommendation of 1.50 for ABT, indicating a Strong Buy sentiment from analysts, might have boosted investor confidence in the stock.
• The technical issues leading to trading halts for NYSE stocks, including ABT, could have created volatility in the market, potentially leading to increased trading activity in ABT as investors sought stability in healthcare stocks.
• Overall, the combination of positive market sentiment towards dividend stocks, favorable analyst recommendations, and technical issues impacting trading on the NYSE likely contributed to ABT's bullish movement today.

16.03.2025 - ABT Stock was up 5.4%

• Abbott Laboratories reported positive Q1 earnings, with sales increasing by 7.2% and adjusted EPS surpassing consensus estimates, potentially influencing the uptick in ABT stock.
• The company's strong performance in the Medical Device segment, notably with products like FreeStyle Libre and heart-related devices, demonstrated its resilience in uncertain times and its ability to drive growth.
• The purchase of a substantial amount of ABT stock by a member of the House of Representatives might have boosted investor confidence in the company's future, leading to increased buying activity and pushing the stock price up.
• Despite the overall market decline witnessed today, Abbott Laboratories' robust financial results, favorable market sentiment, and strategic growth initiatives likely propelled the bullish trend in ABT stock.

20.06.2023 - ABT Stock was up 2.6%

• ABT reported strong Q2 growth in its underlying base business, with organic sales growth of 11.5%.
• Despite a decline in earnings, ABT's results exceeded expectations, leading to a bullish movement in the stock.
• The company's ability to offset declining COVID testing sales with its base business performance contributed to the positive market movement.
• ABT's reaffirmation of its adjusted earnings guidance for the full-year 2023 also boosted investor confidence.

11.09.2023 - ABT Stock was down 1.9%

• The bearish movement in ABT's stock today could be attributed to the following factors:
• 1. Negative sentiment from Jim Cramer: Jim Cramer, a well-known financial commentator, expressed his concerns about the company due to Elon Musk's comment about not liking the business. This might have caused some investors to sell their shares, leading to a bearish market movement.
• 2. Increase in stake by Moody Lynn & Lieberson LLC: Despite the overall bearish movement, Moody Lynn & Lieberson LLC increased its stake in ABT during the second quarter. This suggests that there might be some positive long-term prospects for the company, which could potentially counterbalance the short-term bearish sentiment.
• 3. Overall market conditions: It's important to consider the broader market conditions when analyzing the movement of a specific stock. If the overall market experienced a bearish trend today, it could have influenced ABT's stock as well, regardless of the company's specific news or events.
• In conclusion, the bearish movement in ABT's stock today could be attributed to negative sentiment from Jim Cramer and potentially influenced by the overall market conditions. However, the increase in stake by Moody Lynn & Lieberson LLC indicates some positive long-term prospects for the company.

11.09.2023 - ABT Stock was down 5.2%

• The bearish movement in ABT's stock today could be attributed to the following factors:
• 1. Market shift: Abbott Laboratories is exploring the consumer wearables market as COVID testing sales dwindle. This strategic move might have raised concerns among investors about the company's focus and potential impact on its financial performance.
• 2. Elon Musk's influence: Jim Cramer mentioned on CNBC's "Mad Money" that he is a seller of ABT because Elon Musk stated that he doesn't like that business. Musk's negative sentiment towards the company could have influenced investor sentiment and contributed to the bearish movement.
• 3. Stake increase: Moody Lynn & Lieberson LLC increased its stake in Abbott Laboratories, indicating confidence in the company. However, this positive development might not have been enough to counterbalance other factors affecting the stock's movement.
• 4. Overall market conditions: The bearish movement in ABT's stock could also be a result of broader market trends or sector-specific factors impacting healthcare stocks. It's important to consider the overall market conditions when assessing individual stock movements.

20.01.2024 - ABT Stock was up 1.9%

• Several factors may have contributed to the bullish movement in ABT stock:
• Abbott Laboratories announced a $0.55 dividend, which could have attracted income-seeking investors, thereby increasing the stock's appeal.
• The FDA's Circulatory System Devices Panel provided a favorable recommendation for Abbott's Minimally Invasive Heart Valve Repair Device, the TriClip system, potentially boosting investor confidence in the company's medical innovations.
• An FDA independent panel endorsed the safety profile of Abbott's heart device TriClip, showcasing the company's dedication to pioneering healthcare solutions. This news likely fueled investor confidence and drove the stock price up.

03.06.2023 - ABT Stock was down 1.6%

• The bearish movement in ABT stock could be attributed to the news of a deadly germ, cronobacter, joining the CDC watchlist of bad bugs. This news might have raised concerns about the potential impact on Abbott Laboratories' nutrition segment, which includes infant formula.
• Additionally, the article mentioning Abbott Laboratories as a hold due to its high valuation could have contributed to the bearish movement as investors might have taken a cautious stance.
• It's worth noting that the initiation of coverage on GE HealthCare Technologies by Morgan Stanley with a price target could have also influenced the sentiment in the healthcare sector, potentially impacting ABT stock.

15.02.2024 - ABT Stock was down 5.4%

• ABT stock experienced a bearish trend today possibly due to profit-taking by investors following a period of strong performance.
• Analysts have pointed to discussions on growth in the in-vitro diagnostics market and Roche's AI-based glucose monitoring system launch as factors diverting attention from ABT momentarily.
• The overall optimism in the healthcare industry, exemplified by the Medical Devices ETF reaching a 52-week peak, may have prompted some investors to adjust their portfolios within the sector, impacting ABT's stock performance.
• ABT's sustained outperformance over time, as alluded to by market observations, suggests that today's bearish movement could be a brief correction in the context of the company's favorable long-term trajectory.

08.07.2023 - ABT Stock was down 2.8%

• The bearish movement in ABT today might be attributed to the following factors:
• 1. Options activity: The presence of a large bearish position in ABT options suggests that someone with a significant amount of money has taken a negative stance on the stock. This could have influenced market sentiment and contributed to the bearish movement.
• 2. Dividend considerations: While there is positive sentiment surrounding ABT's dividend, it is possible that some investors are focusing on other aspects of the company's performance, leading to a bearish outlook.
• 3. Comparison with AbbVie: The comparison between Abbott Laboratories and AbbVie, particularly in terms of investment potential, might have influenced market perception. If investors perceive AbbVie as a better investment choice, it could have negatively impacted ABT's stock price.
• Overall, the bearish movement in ABT today could be influenced by options activity, dividend considerations, and comparisons with other companies in the healthcare sector.

17.06.2023 - ABT Stock was down 1.0%

• The bearish movement in ABT's stock today can be attributed to a combination of factors:
• 1. Weight Loss and Weight Management Market Analysis: The article highlighting the increasing prevalence of obesity and the growth in medically supervised weight loss programs may have raised concerns about the demand for Abbott Laboratories' nutrition products, leading to a bearish sentiment.
• 2. Earnings Releases: With a slew of major earnings releases scheduled for next week, including companies like Novartis and Johnson & Johnson, investors might be cautious about the overall performance of the healthcare sector, which could have influenced the bearish movement in ABT's stock.
• 3. Long-Term Performance: The article mentioning Abbott Laboratories' outperformance in the last 10 years might have created profit-taking opportunities for investors, leading to a temporary decline in the stock price.
• 4. Overall Market Volatility: The general market volatility and investor sentiment can also contribute to the bearish movement in ABT's stock, as investors may be adjusting their portfolios and taking a cautious approach.
• In conclusion, the bearish movement in ABT's stock today could be attributed to concerns about the demand for nutrition products, upcoming earnings releases, profit-taking opportunities, and overall market volatility.

18.06.2024 - ABT Stock was down 1.2%

• Despite reporting strong Q2 earnings with EPS beating estimates, Abbott Laboratories (ABT) experienced a bearish movement in its stock.
• The market may have reacted negatively to a slight revenue miss, even though the full-year guidance was raised, indicating potential concerns about future performance.
• Investors might have been expecting higher revenue growth, leading to profit-taking and a bearish trend in the stock price.
• Market sentiment could have been influenced by broader economic conditions or global events, overshadowing the positive earnings beat.